COVID-19 in a cohort of pregnant women and their descendants, the MOACC-19 study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
26 02 2021
Historique:
entrez: 27 2 2021
pubmed: 28 2 2021
medline: 5 3 2021
Statut: epublish

Résumé

The Mother and Child COVID-19 study is a cohort recruiting pregnant women and their children in Cantabria, North of Spain, during COVID-19 pandemic in order to ascertain consequences of SARS-CoV-2 infection on pregnant women and their descendants. This article reports the cohort profile and preliminary results as recruitment is still open. Three subcohorts can be identified at recruitment. Subcohort 1 includes women giving birth between 23 March and 25 May 2020; they have been retrospectively recruited and could have been exposed to COVID-19 only in their third trimester of pregnancy. Subcohort 2 includes women giving birth from 26 May 2020 on; they are being prospectively recruited and could have been exposed to COVID-19 in both their second and third trimesters of pregnancy. Subcohort 3 includes women in their 12 week of pregnancy prospectively recruited from 26 May 2020 on; they could have been exposed to COVID-19 anytime in their pregnancy. All women are being tested for SARS-CoV-2 infection using both RT-PCR for RNA detection and ELISA for anti-SARS-CoV-2 antibodies. All neonates are being tested for antibodies using immunochemoluminiscency tests; if the mother is tested positive for SARS-CoV-2 RNA, a nasopharyngeal swab is also obtained from the child for RT-PCR analysis. As of 22 October, 1167 women have been recruited (266, 354 and 547 for subcohorts 1, 2 and 3, respectively). Fourteen women tested positive to SARS-CoV-2 RNA by the day of delivery. All 14 children born from these women tested negative for SARS-CoV-2 RNA. Children from women included in subcohort 3 are expected to be recruited by the end of 2020. Children will be followed-up for 1 year in order to ascertain the effect that COVID-19 on their development.

Identifiants

pubmed: 33637549
pii: bmjopen-2020-044224
doi: 10.1136/bmjopen-2020-044224
pmc: PMC7918808
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e044224

Investigateurs

Jéssica Alonso-Molero (J)
Bárbara Arozamena (B)
Laura Conde-Gil (L)
Elsa Cornejo Del Río (ECD)
Rocío Cuesta-González (R)
Trinidad Dierssen-Sotos (T)
Pelayo Frank de Zulueta (PF)
Inés Gómez-Acebo (I)
Coral Llano-Ruiz (C)
Lorena Lasarte-Oria (L)
Sonia López-Gómez (S)
Sonia Mateo-Sota (S)
Victoria Orallo (V)
Rosa Pardo (R)
Daniel Pérez González (DP)
María Sáez de Adana Herrero (MS)

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Obstet Gynecol. 2020 Jun;222(6):521-531
pubmed: 32217113
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):795-800
pubmed: 32584802
Nature. 2020 Aug;584(7820):262-267
pubmed: 32512578
BMJ Glob Health. 2020 Sep;5(9):
pubmed: 32999054
Nat Commun. 2020 Jul 14;11(1):3572
pubmed: 32665677
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):769-775
pubmed: 32584795
BJOG. 2020 Nov;127(12):1548-1556
pubmed: 32633022
JAMA Pediatr. 2020 Jul 1;174(7):722-725
pubmed: 32215598
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Clin Infect Dis. 2020 Nov 19;71(16):2035-2041
pubmed: 32249918
Acta Obstet Gynecol Scand. 2020 May;99(5):565-568
pubmed: 32277845
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Am J Obstet Gynecol. 2020 Jul;223(1):111.e1-111.e14
pubmed: 32335053
Viruses. 2020 Feb 10;12(2):
pubmed: 32050635
BJOG. 2020 Aug;127(9):1116-1121
pubmed: 32339382
BMJ. 2020 Jun 8;369:m2107
pubmed: 32513659
BJOG. 2003 Jul;110(7):641-2
pubmed: 12842052
JAMA. 2020 Jul 28;324(4):390-392
pubmed: 32556085
Int J Environ Res Public Health. 2020 Jun 30;17(13):
pubmed: 32630048
Am J Obstet Gynecol. 2020 Jul;223(1):36-41
pubmed: 32311350
Lancet. 2020 Aug 22;396(10250):530-531
pubmed: 32771084
Acta Obstet Gynecol Scand. 2020 Jul;99(7):839-847
pubmed: 32441332
Am J Perinatol. 2020 Jun;37(8):861-865
pubmed: 32305046
Int Breastfeed J. 2020 Sep 9;15(1):79
pubmed: 32907592
JAMA. 2020 May 12;323(18):1848-1849
pubmed: 32215589
Int J Epidemiol. 2020 Oct 1;49(5):1454-1467
pubmed: 32814959
BMC Med. 2020 May 29;18(1):160
pubmed: 32466757
Front Pediatr. 2020 Mar 16;8:104
pubmed: 32266184
BMC Med. 2020 Oct 22;18(1):332
pubmed: 33087179
Int Breastfeed J. 2020 Aug 8;15(1):69
pubmed: 32770999
Acta Obstet Gynecol Scand. 2020 Jul;99(7):819-822
pubmed: 32386441
Acta Obstet Gynecol Scand. 2020 Jul;99(7):823-829
pubmed: 32259279
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Br J Surg. 2020 Sep;107(10):e405-e406
pubmed: 32770538

Auteurs

Javier Llorca (J)

Universidad de Cantabria Facultad de Medicina, Santander, Cantabria, Spain javier.llorca@unican.es.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Carolina Lechosa-Muñiz (C)

Breastfeeding Coordinator, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain.

Pilar Gortazar (P)

Universidad de Cantabria Facultad de Medicina, Santander, Cantabria, Spain.
Servicio de Pediatría, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain.

María Fernández-Ortiz (M)

Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Cantabria, Spain.

Yolanda Jubete (Y)

Universidad de Cantabria Facultad de Medicina, Santander, Cantabria, Spain.
Servicio de Obstetricia y Ginecología, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain.

Maria J Cabero (MJ)

Universidad de Cantabria Facultad de Medicina, Santander, Cantabria, Spain.
Servicio de Pediatría, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain.
Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Cantabria, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH